Prosecution Insights
Last updated: April 19, 2026

Juno Therapeutics Inc.

14 pending office actions

Portfolio Summary

14
Total Pending OAs
3
Final Rejections
11
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18488850 EPIGENETIC ANALYSIS OF CELL THERAPY AND RELATED METHODS DAUNER, JOSEPH G 1682 Final Rejection Oct 17, 2023
18365950 CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR GPRC5D AND BCMA DUNN, LINDSAY MICHELLE 1644 Non-Final OA Aug 04, 2023
18019460 ANTI-IDIOTYPIC ANTIBODIES TO ROR1-TARGETED BINDING DOMAINS AND RELATED COMPOSITIONS AND METHODS SUNSHINE, HANNAH LOUISE 1647 Non-Final OA Feb 02, 2023
17921614 COMBINATION OF BCMA-DIRECTED T CELL THERAPY AND AN IMMUNOMODULATORY COMPOUND JOHNSON, CHRISTOPHER LINDSAY 1691 Final Rejection Oct 26, 2022
17921291 STABILIZATION OF POLYETHYLENEIMINE-DEOXYRIBONUCLEIC ACID COMPLEX SIZE AND ACTIVITY BURKHART, MICHAEL D 1638 Non-Final OA Oct 25, 2022
17917923 METHODS AND USES RELATED TO CELL THERAPY ENGINEERED WITH A CHIMERIC ANTIGEN RECEPTOR TARGETING B-CELL MATURATION ANTIGEN STOICA, ELLY GERALD 1647 Non-Final OA Oct 07, 2022
17799239 BCMA-DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL COMPOSITIONS AND METHODS AND USES THEREOF GRABER, JAMES J 1631 Non-Final OA Aug 11, 2022
17850875 METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY WEHBE, ANNE MARIE SABRINA 1634 Final Rejection Jun 27, 2022
17774821 COMBINATION OF A T CELL THERAPY AND (S)-3-[4-(4-MORPHOLIN-4-YLMETHYL-BENZYLOXY)-L-OXO-L,3-DIHYDRO-ISOINDOL-2-YL]-PIPERIDINE-2,6-DIONE BUTTICE, AUDREY L 1647 Non-Final OA May 05, 2022
17774464 METHODS OF DETERMINING ATTRIBUTES OF THERAPEUTIC T CELL COMPOSITIONS BAILEY, STEVEN WILLIAM 1687 Non-Final OA May 04, 2022
17297771 METHODS FOR TREATMENT USING ADOPTIVE CELL THERAPY LU, CHENG 1642 Non-Final OA May 27, 2021
17291536 PROCESS FOR PRODUCING GENETICALLY ENGINEERED T CELLS VAN BUREN, LAUREN K 1638 Non-Final OA May 05, 2021
17266995 METHODS FOR ASSESSING INTEGRATED NUCLEIC ACIDS ZAHORIK, AMANDA MARY 1636 Non-Final OA Feb 08, 2021
16634497 REAGENTS FOR EXPANDING CELLS EXPRESSING RECOMBINANT RECEPTORS KIM, YUNSOO 1641 Non-Final OA Jan 27, 2020

Managing Juno Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month